CYP11A1 and melanoma: CNA data demonstrate that the CYP11A1 gene was amplified at ~1.5%, ~1.4%, ~3%, ~1.6%, and ~1.1% in breast, melanoma, ovarian, pancreatic, and uterine endometrial cancers, respectively (Figure 4A).